Penetration-enhancing effect of the essential oil and methanolic extract of eryngium bungei on percutaneous absorption of piroxicam through rat skin

Journal of Essential Oil-Bearing Plants

Volumn 12, Issue 6, 2009, Pages 728-741

  Saeedi, Majid ^a,b   Morteza Semnani, Katayoun ^a,b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

E. bungei; Essential oil; Extract; GC MS; Penetration enhancer; Percutaneous; Piroxicam

Indexed keywords

ERYNGIUM; RATTUS;

EID: 77953046195     PISSN: 0972060X     EISSN: None     Source Type: Journal    
DOI: 10.1080/0972060X.2009.10643782     Document Type: Article

References (39)

1. Santoyo, S., Arellano, A., Ygartua, P., Martin, C. (1995). Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin, Int. J. Pharm. 117:219–224.
2. Femenia-Font, A., Balaguer-Fernandez, C., Merino, V., Rodilla, V., Lopez-Castellano, A. (2005). Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate, Eur. J. Pharm. Biopharm. 61:50–55.
3. Huang, Y.B., Wu, P.C., Ko, H.M., Tsai, Y.H. (1996). Effect of pretreatment by cardamom oil on in vitro percutaneous penetration of piroxicam gel, Int. J. Pharm. 131:137–141.
4. Huang, Y.B., Hsu, L.R., Wu, P.C., Ko, H.M., Tsai, Y.H. (1993). Crude drug (Zingiberaceae) enhancement of percutaneous absorption of indomethacin:in vitro and in vivo permeation, Kao-Hsiung I Hsueh Ko Hsueh Tsa Chih (Kaohsiung J. Med. Sci.) 9:392–400.
5. Cornwell, P.A., Barry, B.W. (1994). Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-flourouracil, J. Pharm. Pharmacol. 46:261–269.
6. Abdullah, D., Ping, Q.N., Liu, G.J. (1996). Enhancing effect of essential oils on the penetration of 5-fluorouracil through rat skin, Yao Hsueh Hsueh Pao (Acta Pharmaceutica Sinica) 31:214–221.
7. Arellano, A., Santoyo, S., Martin, C., Ygartua, P. (1996). Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium, Int. J. Pharm. 130:141–145.
8. Huang, Y.B., Fang, J.Y., Hung, C.H., Wu, P.C., Tsai, Y.H. (1999). Cyclic monoterpene extract from cardamom oil as a skin permeation enhancer for indomethacin:in vitro and in vivo studies, Biol. Pharmaceut. Bull. 22(6):642–646.
9. Ceschel, G C., Maffei, P., Moretti, M.D.L., Demontis, S., Peana, A.T. (2000).In vitro permeation through porcine buccal mucosa of Salvia desoleana Atzei & Picci essential oil from topical formulation, Int. J. Pharm. 195:171–177.
10. Doliwa, A., Santoyo, S., Ygartua, P. (2001). Effect of passive and iontophoretic skin pretreatments with terpenes on the in vitro skin transport of piroxicam, Int. J. Pharm. 229:37–44.
11. Nokhodchi, A., Nazemiyeh, H., Ghafourian, T., Hassan-Zadeh, D., Valizadeh, H., Bahary, L.A.S. (2002). The effect of glycyrrhizin on the release rate and skin penetration of diclofenac sodium from topical formulation, Il Farmaco, 57:883–888.
12. Fang, J.Y., Leu, Y.L., Hwang, T.L., Cheng, H.C. (2004). Essential oils from sweet basil (Ocimum basilicum) as novel enhancers to accelerate transdermal drug delivery, Biol. Pharmaceut. Bull. 27(11):1819–1825.
13. Das, M.K., Bhattacharya, A., Ghosal, S.K. (2006). Effect of different terpenecontainingessential oils on percutaneous absorption of trazodone hydrochloride through mouse epidermis, Drug Del. 13(6):425–431.
14. Zhang, L.C., Gao, L.H., Hu, J.H., Yan, C.X., Zhu, Q.G (2006). Enhancing effect of essential oils from Ligusticum chuanxiong Hort, on the permeation of flurbiprufen through isolated rat skin, Pharmaceut. Care Res. 6(6):413–416.
15. Gao, S., Singh, J. (1997). Mechanism of transdermal transport of 5-fluorouracil by terpenes:carvone, 1,8-cineole and thymol, Int. J. Pharm. 154:67–77.
16. Krishnaiah, Y.S.R., Shiva Kumar, M., Raju, V., Lakshmi, M., Rama, B. (2008). Penetration enhancing effect of ethanolic solution of menthol on transdermal permeation of ondansetron HCl across rat skin, Drug Del. 15(4):227–234.
17. Mozaffarian, V. (1996). A Dictionary of Iranian Plant Names, Farhang Mo’aser Publishers, Tehran, Iran, pp. 214–215.
18. Rechinger, K.H. (1987). Flora Iranica, Akademische Druck-U.Verlagsanstalt, Graz, Austria, No. 162, pp. 57–59.
19. Zargari, A. (1992). Medicinal Plants, Tehran University Publications, Tehran, Iran, vol. 2, pp. 616–619.
20. Davies, N.W. (1990). Gas chromatographic retention indices of monoterpenes and sesquiterpenes on methyl silicone and carbowax 20M phases. J. Chromatogr., 503:1–24.
21. Adams, R.P. (2001). Identification of Essential Oil Components by Gas Chromatography/ Quadrupole Mass Spectroscopy. Allured Publishing Corp., Carol Stream, IL.
22. Saeedi, M., Kosaryan, M., Fekri, K., Adabi, M., Mahdavi, M.R. (2007). A randomized double blind, controlled trial of testosterone gel treatment versus vehicle control on the facial hair of young men with beta-thalassemia major, J. Dermatol. Treat. 18:271–274.
23. Adrangui, M., Aghaei, M., Saeedi, M. (1994). Effect of formulation on release and percutaneous absorption of hydroquinone from O/W cream base, Pharm. Sci. (Journal of Faculty of Pharmacy, Tabriz Univ Med Sci), 3(3):100–106.
24. Saeedi, M., Morteza-Semnani, K. (2008). Effect of essential oil of Eryngium caeruleum on percutaneous absorption of piroxicam through rat skin, J. Essent. Oil Bearing Plants, 11(5):485–495.
25. Kupeli, E., Kartal, M., Aslan, S., Yesilada, E. (2000). Comparative evaluation of anti-inflammatory and antinociceptive activity of Turkish Eryngium species, J. Ethnopharm. 107:32–37.
26. Saenz, M.T., Fernandez, M.A., Garcia, M.D. (1997). Anti-inflammatory and analgesic properties from laves of Eryngium foetidum L. (Apiaceae), Phytother. Res. 11:380–383.
27. Sekiya, K., Kadota, S., Katayama, K., Koizumi, T., Namba, T. (1997). Study on baths with crude drug. III. The effect of ligustici chuanxiong rhizoma extract on the percutaneous absorption of some natural compounds. Biol. Pharm. Bull. 20(9):983–987.
28. Morteza-Semnani, K. (2005). Essential Oil Composition of Eryngium bungei Boiss., J. Essent. Oil. Res. 17(Sep./Oct.):485–486.
29. Kunta, J.R., Goskonda, V.R., Brotherton, H.O., Khan, M.A., Reddy, I. (1997). Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J. Pharm. Sci. 86:1369–1373.
30. Okabe, H., Takayama, K., Ogura, A., Nagai, T. (1989). Effect of limonene and related compounds on the percutaneous absorption of indomethacin. Drug Des. Del. 4:313–321.
31. Williams, A.C., Barry B.W. (1989). Essential oils as novel human skin penetration enhancers. Int. J. Pharm. 57:R7-R9.
32. Tas, C., Ozkan, Y., Okyar, A., Savaser, A. (2007).In vitro and ex vivo studies of etodolac from hydrophilic gels and effect of terpenes as enhancers, Drug Del. 14(7):453–459.
33. Nakamura, Y., Takayama, K., Higashiyama, K., Suzuki, T., Nagai, T. (1996). Promoting effect of O-ethylmenthol on the percutaneous absorption of indomethacin. Drug Des. Deliv. 145:29–36.
34. Goodman, M., Barry, B.W. (1998). Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and oestradiol:I. Infmite dose technique. J. Invest. Dermatol. 91:323–327.
35. Yamane, M.A., Williams, A.C., Barry, B.W. (1995). Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetery. Int. J. Pharm. 116:237–251.
36. Jain, A.K., Thomas, N.S., Pachagnula, R. (2002). Transdermal drug delivery of imipramine hydrochloride. J. Control. Rel. 79:93–101.
37. Williams, A.C., Barry, B.W. (1991). Terpenes and lipid protein partitioning theory of skin penetration enhancement. Pharm. Res. 8:17–24.
38. Komata, Y., Inoaka, M., Kaneko, A., Fujie, T. (1992).In vitro percutaneous absorption of thiamine disulfide from a mixture of propylene glycol and fatty acid. J. Pharm. Sci. 81:744–746.
39. Santoyo, S., Ygartua, P. (2000). Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application, Eur. J. Pharm. Biopharm. 50:245–250.